Literatur
-
1
Keller M B, Klein D N, Hirschfeld R M. et al .
Results of the DSM-IV mood disorders field trial.
American Journal of Psychiatry.
1995;
152
843-849
-
2
Kennedy N, Abbott R, Paykel E S.
Remission and recurrence of depression in the maintenance era: long-term outcome in a Cambridge cohort.
Psychological Medicine.
2003;
33
827-838
-
3 Hiller W, Zaudig M, Mombour W. IDCL - Internationale Diagnosen Checklisten für ICD-10 und DSM-IV. Bern; Hans Huber 1997
-
4 Wittchen H U, Wunderlich U, Gruschwitz S, Zaudig M. Strukturiertes klinisches Interview für DSM-IV (SKID). Göttingen; Hogrefe 1997
-
5
McCullough J P, McCune K J, Kaye A L. et al .
One-year prospective replication study of an untreated sample of community dysthymia subjects.
Journal of Nervous and Mental Disease.
1994;
182
396-401
-
6
Russell J M, Kornstein S G, Shea M T. et al .
Chronic depression and comorbid personality disorders: response to sertraline versus imipramine.
Journal of Clinical Psychiatry.
2003;
64
554-561
-
7
Berndt E R, Koran L M, Finkelstein S N. et al .
Lost human capital from early-onset chronic depression.
American Journal of Psychiatry.
2000;
157
940-947
-
8
Kennedy N, Abbott R, Paykel E S.
Remission and recurrence of depression in the maintenance era: long-term outcome in a Cambridge cohort.
Psychological Medicine.
2003;
33
827-838
-
9
Kennedy N, Paykel E S.
Residual symptoms at remission from depression: impact on long-term outcome.
Journal of Affective Disorders.
2004;
80
135-144
-
10
Melartin T K, Rytsala H J, Leskela U S.
Severity and comorbidity predict episode duration and recurrence of DSM-IV major depressive disorder.
Journal of Clinical Psychiatry.
2004;
65
810-819
-
11
Grilo C, Sanislow C, Shea M. et al .
Two-year prospective naturalistic study of remission from major depressive disorder as a function of personality disorder comorbidity.
J Consult Clin Psychol.
2005;
73
78-85
-
12
Gilmer W S, Trivedi M H, Rush A J. et al .
Factors associated with chronic depressive episodes: a preliminary report from the STAR-D project.
Acta Psychiatrica Scandinavica.
2005;
112
425-433
-
13
Green B L, Krupnick J L, Chung J. et al .
Impact of PTSD comorbidity on one-year outcomes in a depression trial.
J Clin Psychol.
2006;
62
815-835
-
14
Agosti V, Levin F R.
The effects of alcohol and drug dependence on the course of depression.
American Journal of Addiction.
2006;
15
71-75
-
15
Miller I W, Keitner G I, Schatzberg A F. et al .
The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramine.
Journal of Clinical Psychiatry.
1998;
59
608-619
-
16
Nierenberg A A, Fava M, Trivedi M H. et al .
A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR-D report.
American Journal of Psychiatry.
2006;
163
1519-1530
-
17
Fava M, Rush A J, Wisniewski S R. et al .
A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR-D report.
American Journal of Psychiatry.
2006;
163
1161-1172
-
18
Schatzberg A F, Rush A J, Arnow B A. et al .
Chronic depression: medication (nefazodone) or psychotherapy (CBASP) is effective when the other is not.
Archives of General Psychiatry.
2005;
62
513-520
-
19
Thase M E, Simons A D, Reynolds C F.
Psychobiological correlates of poor response to cognitive behavior therapy: potential indications for antidepressant pharmacotherapy.
Psychopharmocology Bulletin.
1993;
29
293-301
-
20
Agosti V, Ocepek-Welikson K.
The efficacy of imipramine and psychotherapy in early-onset chronic depression: a reanalysis of the National Institute of Mental health Treatment of Depression Collaborative Research Program.
Journal of Affective Disorders.
1997;
43
181-186
-
21
McCullough J P, McCune K J, Kaye A L. et al .
Comparison of a community dysthymia sample at screening with a matched group of nondepressed community controls.
Journal of Nervous and Mental Disease.
1994;
182
402-407
-
22
Keller M B, McCullough J P, Klein D N. et al .
A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression.
New England Journal of Medicine.
2000;
342
1462-1470
-
23
Nemeroff C B, Heim C M, Thase M E. et al .
Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma.
Proc Natl Acad Sci USA.
2003;
100
14293-14296
-
24
Manber R, Arnow B, Blasey C. et al .
Patient's therapeutic skill acquisition and response to psychotherapy, alone or in combination with medication.
Psychological Medicine.
2003;
33
693-702
-
25
Klein D, Santiago N J, Vivian D. et al .
Cognitive-behavioral analysis system of psychotherapy as a maintenance treatment for chronic depression.
J Consult Clin Psychol.
2004;
72
681-688
-
26 McCullough J P. Treatment for chronic depression. Cognitive behavioral analysis system of psychotherapy (CBASP). New York; Guilford 2000
-
27 McCullough J P. Psychotherapie der chronischen Depression. Cognitive Behavioral Analysis System of Psychotherapy - CBASP. München; Urban & Fischer 2006
-
28 McCullough J P. Skills training manual for diagnosing & treating chronic depression. New York; Guilford 2001
-
29 McCullough J P. Patient's manual for CBASP. New York; Guilford 2003
-
30
Teasdale J D, Moore R G, Hayhurst H, Pope M, Williams S, Segal Z V.
Metacognitive awareness and prevention of relapse in depression: empirical evidence.
Journal of Consulting and Clinical Psychology.
2002;
70
275-287
Prof. Dr. med. Ulrich Schweiger
Klinik für Psychiatrie und Psychotherapie
Universität zu Lübeck
Ratzeburger Allee 160
23538 Lübeck
Telefon: + 49-451-500-2454
eMail: ulrich.schweiger@psychiatrie.uk-sh.de
